Market Cap 1.22M
Revenue (ttm) 3.02M
Net Income (ttm) -8.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -265.89%
Debt to Equity Ratio -56.50
Volume 188,200
Avg Vol 71,821
Day's Range N/A - N/A
Shares Out 666,000.00
Stochastic %K 56%
Beta 2.03
Analysts Strong Sell
Price Target $6.00

Company Profile

INVO Fertility, Inc., a life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases. The company operates in two divisions, NAYA Women's Health and NAYA Therapeutics. Its lead product includes NY-303, a GPC3-targeted FLEX-NK bispecific antibody that is in Phase I/II clinical trials for hepatocellular carcinoma, as well as solid and pediatric tumors; and NY-338, a CD38-targeted FLEX-NK bispecific antibody for multiple myeloma...

Industry: Medical Devices
Sector: Healthcare
Phone: 978-878-9505
Address:
5582 Broadcast Court, Sarasota, United States
Latest News on NAYA
No data available.